Data from two Phase 3 studies of cystic fibrosis investigational medicine Orkambi published
18 May 2015 | By Victoria White
Data from two Phase 3 studies of Orkambi, an investigational medicine designed to treat the underlying cause of cystic fibrosis, have been published...